(Q45057604)

9 December 2017

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction (English)

1 reference

9 December 2017

1 reference

1

1 reference

9 December 2017

Hans-Hellmut Neumayer

5

object named as

Hans H Neumayer

1 reference

9 December 2017

Klemens Budde

2

1 reference

9 December 2017

Federico Oppenheimer

3

1 reference

9 December 2017

Lutz Fritsche

4

1 reference

9 December 2017

Josep M Campistol

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

American Journal of Transplantation

9 December 2017

1 reference

9 December 2017

4

1 reference

9 December 2017

11

1 reference

9 December 2017

1869-1875

1 reference

Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil

9 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Renal insufficiency after heart transplantation: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Conversion to sirolimus in solid organ transplantation: a Single-Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00590.X

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.1111/J.1600-6143.2004.00590.X

1 reference

9 December 2017

1 reference